BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16619529)

  • 21. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1.
    Wang Y; Friedl W; Sengteller M; Jungck M; Filges I; Propping P; Mangold E
    Hum Mutat; 2002 Mar; 19(3):279-86. PubMed ID: 11857745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of DNA-mismatch repair gene expression in oral melanomas.
    Korabiowska M; Brinck U; Ruschenburg I; Honig JF; Stachura J; Droese M
    Oncol Rep; 1999; 6(4):921-3. PubMed ID: 10373682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC).
    Li L; McVety S; Younan R; Liang P; Du Sart D; Gordon PH; Hutter P; Hogervorst FB; Chong G; Foulkes WD
    Hum Mutat; 2006 Apr; 27(4):388. PubMed ID: 16541406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing.
    Auclair J; Busine MP; Navarro C; Ruano E; Montmain G; Desseigne F; Saurin JC; Lasset C; Bonadona V; Giraud S; Puisieux A; Wang Q
    Hum Mutat; 2006 Feb; 27(2):145-54. PubMed ID: 16395668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2.
    Beiner ME; Rosen B; Fyles A; Harley I; Pal T; Siminovitch K; Zhang S; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1636-40. PubMed ID: 16985024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
    Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
    Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The analysis for mRNA mutation of MLH1, MSH2 genes and the gene diagnosis for hereditary nonpolyposis colorectal cancer].
    Wang CF; Zhou XY; Zhang TM; Sun MH; Xu Y; Shi DR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):32-6. PubMed ID: 16456782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.
    Charbonnier F; Olschwang S; Wang Q; Boisson C; Martin C; Buisine MP; Puisieux A; Frebourg T
    Cancer Res; 2002 Feb; 62(3):848-53. PubMed ID: 11830542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin.
    Korabiowska M; Tscherny M; Stachura J; Ruschenburg I; Cordon-Cardo C; Brinck U
    In Vivo; 2002; 16(5):317-21. PubMed ID: 12494870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments.
    Charbonnier F; Raux G; Wang Q; Drouot N; Cordier F; Limacher JM; Saurin JC; Puisieux A; Olschwang S; Frebourg T
    Cancer Res; 2000 Jun; 60(11):2760-3. PubMed ID: 10850409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of hereditary nonpolyposis colorectal cancer.
    Akrami SM
    Arch Iran Med; 2006 Oct; 9(4):381-9. PubMed ID: 17061614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
    Balmaña J; Stockwell DH; Steyerberg EW; Stoffel EM; Deffenbaugh AM; Reid JE; Ward B; Scholl T; Hendrickson B; Tazelaar J; Burbidge LA; Syngal S
    JAMA; 2006 Sep; 296(12):1469-78. PubMed ID: 17003395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.
    Stark AM; Doukas A; Hugo HH; Hedderich J; Hattermann K; Maximilian Mehdorn H; Held-Feindt J
    Neurol Res; 2015 Feb; 37(2):95-105. PubMed ID: 24995467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three novel germline mutations in MLH1 and MSH2 in families with Lynch syndrome living on Jeju island, Korea.
    Kim YM; Choe CG; Cho SK; Jung IH; Chang WY; Cho M
    BMB Rep; 2010 Oct; 43(10):693-7. PubMed ID: 21034533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.
    Ollila S; Sarantaus L; Kariola R; Chan P; Hampel H; Holinski-Feder E; Macrae F; Kohonen-Corish M; Gerdes AM; Peltomäki P; Mangold E; de la Chapelle A; Greenblatt M; Nyström M
    Gastroenterology; 2006 Nov; 131(5):1408-17. PubMed ID: 17101317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
    Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
    Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of in situ hybridization probes for MLH-1 and MSH-2 in tissue microarrays of paraffin-embedded malignant melanomas: correlation with immunohistochemistry and tumor stage.
    Korabiowska M; Cordon-Cardo C; Jaenckel F; Stachura J; Fischer G; Brinck U
    Hum Pathol; 2004 Dec; 35(12):1543-8. PubMed ID: 15619215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of mutS homolog 2 and mutL homolog 1 affects overall survival in laryngeal squamous cell carcinoma patients: Investigation into a potential cause.
    Gong HL; Shi Y; Shi Y; Wu CP; Cao PY; Zhou L; Xu C
    Oncol Rep; 2013 Sep; 30(3):1371-9. PubMed ID: 23787767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.